This increase in fusion (MFN1 and MFN2) and decrease in fission (FIS1) contribute to an increase in overall mitochondrial function, leading to a decrease in adiposity in HF fed mice, a consequent reduction in obesity, and a concurrent reduction in the development of NASH. The gene discussed is FIS1; the disease is metabolic dysfunction-associated steatohepatitis.